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Abstract
Leishmania parasites alternate between extracellular promastigotes in sandflies and intracellular amastigotes in mammals.
These protozoans acquire sphingolipids (SLs) through de novo synthesis (to produce inositol phosphorylceramide) and
salvage (to obtain sphingomyelin from the host). A single ISCL (Inositol phosphoSphingolipid phospholipase C-Like)
enzyme is responsible for the degradation of both inositol phosphorylceramide (the IPC hydrolase or IPCase activity) and
sphingomyelin (the SMase activity). Recent studies of a L. major ISCL-null mutant (iscl
2) indicate that SL degradation is
required for promastigote survival in stationary phase, especially under acidic pH. ISCL is also essential for L. major
proliferation in mammals. To further understand the role of ISCL in Leishmania growth and virulence, we introduced a sole
IPCase or a sole SMase into the iscl
2 mutant. Results showed that restoration of IPCase only complemented the acid
resistance defect in iscl
2 promastigotes and improved their survival in macrophages, but failed to recover virulence in mice.
In contrast, a sole SMase fully restored parasite infectivity in mice but was unable to reverse the promastigote defects in
iscl
2. These findings suggest that SL degradation in Leishmania possesses separate roles in different stages: while the IPCase
activity is important for promastigote survival and acid tolerance, the SMase activity is required for amastigote proliferation
in mammals. Consistent with these findings, ISCL was preferentially expressed in stationary phase promastigotes and
amastigotes. Together, our results indicate that SL degradation by Leishmania is critical for parasites to establish and sustain
infection in the mammalian host.
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Introduction
Trypanosomatid protozoans of the genus Leishmania are vector-
borne pathogens responsible for a variety of serious diseases known
as leishmaniasis [1,2]. During their life cycle, these organisms
alternate between flagellated promastigotes living in the gut of
sandflies and non-flagellated amastigotes residing in mammalian
phagocytes. Current drugs for leishmaniasis are inadequate and no
safe vaccine is available [3]. A better understanding of Leishmania-
host interaction is needed to develop new cost-effective medica-
tions.
In many eukaryotes, sphingolipids (SLs) are important cell
membrane components and their metabolites such as ceramide
and sphingosine-1-phosphate control multiple processes including
cell growth, differentiation and apoptosis [4,5]. The most
abundant SL in mammals is sphingomyelin (SM) and the
degradation of SM is catalyzed by a group of sphingomyelinases
(SMases), which sever the phosphodiester bond to generate
ceramide and phosphocholine. In mammals, three classes of
SMases (acid SMases, neutral SMases, and alkaline SMases) have
been identified with distinct pH preferences [6,7]. Among them,
the Mg
2+-dependent neutral SMases are the major contributors
for mediating stress-induced ceramide production [8].
Different from mammals, fungal cells synthesize little or no SM;
instead, the majority of SLs in fungi belong to inositol
phosphorylceramide (IPC) and its glycosylated derivatives [9].
Besides fungi, IPC-based SLs are also found in plants and
Trypanosomatids but not in mammals [10,11]. In Saccharomyces
cerevisiae, a neutral SMase homolog named ScISC1 is responsible
for breaking down IPC into ceramide and phosphoinositol (the
‘‘IPCase’’ activity) [12]. ScISC1 also possesses neutral SMase
activity even though S. cerevisiae cells do not synthesize SM [12].
ScISC1 was predominantly found in the endoplasmic reticulum
during early growth but became associated with mitochondria
during the later stages [13]. This change of localization might
lead to the activation of ScISC1, which was dependent on
anionic, mitochondrial phospholipids such as phosphatidylgly-
cerol and cardiolipin [14]. Deletion of ScISC1 resulted in a slow
growth phenotype and increased sensitivity to heat and oxidative-
stress [15], suggesting that controlled ceramide production played
a role in maintaining normal mitochondrial functions such as
respiration or utilization of non-fermentable carbon sources[14].
Another study indicates that ScISC1-induced mitochondrial
adaptation may also affect gene expression during the transition
from anaerobic to aerobic metabolism [16]. In Cryptococcus
neoformans (an opportunistic fungal pathogen), IPC degradation
is mediated by CnISC1, a homolog of ScISC1 and mammalian
neutral SMase [17]. The activity of CnISC1 was implicated in
the survival of this organism in macrophages and its dissemina-
tion to the central nervous system in mice [17]. Unlike ScISC1
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IPCase activity [18].
Similar to fungi, Leishmania parasites do not synthesize SM but
are highly abundant in IPC [19,20]. Nonetheless, they possess a
potent SMase activity [21], suggesting that these parasites may
metabolize SM from the mammalian host. We recently identified
an inositol phosphosphingolipid phospholipase C-like (ISCL)
protein as the sole homolog of mammalian neutral SMase and
fungal ISC1 in L. major [21]. Deletion of ISCL led to a complete
loss of SMase and IPCase activity, suggesting this enzyme was
required for the turnover of both parasite- and host-derived SLs
[21]. In culture, ISCL-null mutants (referred to as iscl
2) had a
normal doubling time during the log phase but were more round
in shape and less healthy compared to wild type (WT) parasites
during the stationary phase [21]. Importantly, iscl
2 parasites failed
to proliferate or cause pathology in either immunocompetent or
immunodeficient mice [22]. This virulence defect could be fully
rescued when iscl
2 mutants were complemented with either
ScISC1 or mammalian neutral SMases, which, like ISCL, could
degrade both SM and IPC [21]. However, a pure IPCase such as
CnISC1 failed to restore the virulence of iscl
2 in mice, suggesting
that the degradation of host-derived SM, not endogenous IPC,
was required for Leishmania survival in the mammalian host [21].
The neutral SMase activity (mediated by an ISCL ortholog) is also
found to be essential for the survival of Trypanosoma brucei (a
Trypanosomatid pathogen related to Leishmania species) during the
bloodstream stage and involved in the trafficking of variant surface
glycoprotein [23].
Iscl
2 parasites exhibited very poor viability when they were
cultured in a pH 5.0 medium (which mimicked the condition in
mammalian phagolysosomes) to stationary phase [22]. This result
suggests that SL degradation is important for conferring acid
resistance [22]. The hypersensitivity of iscl
2 to acidic pH is
responsible for its poor survival in murine macrophages [22], the
definitive host cells for Leishmania. Since ISCL is both a neutral
SMase and an IPCase, it is of interest to determine which activity
is required for acid tolerance and whether the restoration of acid
resistance is sufficient to recover the virulence of iscl
2 in mammals.
In this study, we analyzed the spatial and temporal expression of
ISCL in L. major. We also probed the function of SMase and
IPCase through complementation studies of iscl
2. Our results
indicate that SL degradation is developmentally regulated and
possesses distinct roles during different stages of Leishmania life
cycle.
Results
Spatial and temporal expression of ISCL in Leishmania
To determine if ISCL expression changes during L. major life
cycle, we examined its mRNA- and protein-levels in WT parasites.
First, quantitative RT-PCR analysis revealed a significant increase
of ISCL transcript (10,45-fold) when log phase promastigotes
entered stationary phase (Fig. 1A). During the same time period, we
detected an 8,10-fold increase in the cellular abundance of ISCL
protein by western-blot (Fig. 1B). The discrepancy in relative
abundance between ISCL mRNA and protein may be due to
posttranscriptional regulation (e.g. control of mRNA turnover and
translation). ISCL protein was also highly expressed in WT
amastigotes (purified from infected BALB/c mice) and iscl
2/+ISCL
promastigotes (the ‘‘add-back’’ control for iscl
2 in which ISCL was
expressed from a high-copy vector [21]) (Fig. 1B). In Leishmania,l a t e
stationary phase promastigotes (containing metacyclics [24]) and
amastigotes are highly infective to mammals whereas log phase
promastigotesarenotvirulent.Therefore,thestage-dependent ISCL
expression suggests that SL degradation may contribute to
Leishmania infection. Also of note is that the expression profile
of ISCL is opposite to that of serine palmitoyltransferase, an
enzyme required for the de novo synthesis of SLs, which is
abundant in log phase but downregulated in late stationary phase
and amastigotes [20].
Previously, we examined the localization of a GFP-tagged ISCL
that was overexpressed from an episomal vector and results
showed that GFP-ISCL was associated with the mitochondrion in
promastigotes [21]. Here we investigated the localization of
endogenous ISCL in WT parasites using a rabbit anti-ISCL
peptide antibody. As shown in Fig. 1C–F, the distribution of ISCL
largely overlapped with the staining of mitochondrion by
Mitotracker in promastigotes. A similar localization was observed
in WT amastigotes isolated from L. major-infected mice (Fig. 1G–J).
Together, these results suggest that ISCL is mainly located in the
mitochondrion in Leishmania.
Functional analysis of ISCL by mutagenesis
Similar to its homolog in S. cerevisiae (ScISC1) [25], the ISCL
protein contains 2 predicted transmembrane helices (AA447–466
and AA612–634) near its C-terminus (Fig. 2A and Fig. S1). Studies
on ScISC1 suggest that the C-terminal domain (including those
transmembrane helices) is required for anionic phospholipid
binding and the tethering of N-terminal catalytic domain to
mitochondrial membrane [26,27]. For ISCL, it is not known
whether these transmembrane helices are essential for its catalytic
activity or its mitochondrial localization. To determine if the C-
terminal domain is required for the function of ISCL, we
generated a truncated ISCL (ISCLD) by removing the last 206
amino acid residues (AA448–653) (Figs. 2A and S1). In addition,
we changed 3 Asp residues (D116, D200, and D383) in the
predicted catalytic domain of ISCL to glycine through site-
directed mutagenesis (Figs. 2A and S1). These Asp residues were
conserved among the neutral SMase family and might be required
for catalysis based on studies of the Bacillus cereus SMase and
ScISC1 [28,29]. In particular, D116 was located within a P-loop-
like motif (AA115–121, Fig. S1) which was highly conserved in
nucleotide-binding proteins and might be involved in Mg
2+
binding [26,28]. The change from Asp (acidic) to a neutral amino
acid such as glycine could drastically affect the function of ISCL.
To test if these Asp residues and transmembrane regions were
required for SMase/IPCase activity, modified forms of ISCL
(D116G, D200G, D383G, and ISCLD) were cloned in a Leishmania
expression vector (pXG) [30] and introduced into iscl
2 parasites
via transfection. We then examined the SMase and IPCase activity
in those iscl
2 transfectants (referred to as iscl
2/+ISCL D116G,
iscl
2/+ISCL D200G, iscl
2/+ISCL D383G, and iscl
2/+ ISCLD).
As summarized in Fig. 2B–D, mutations of D116G, D200G, and
D383G completely abolished the enzymatic activity of ISCL
without significantly affecting protein steady state level. Removing
the C-terminal domain not only ablated the function of ISCL
(Fig. 2C–D), but also might reduce its stability as suggested by
Western-blot (Fig. 2B). Alternatively, the lack of C-terminal region
might alter the overall conformation of ISCLD leading to lower
affinity to the anti-ISCL antibody used in the Western-blot (the
peptide recognized by the anti-ISCL antibody is shown in Fig. S1).
Thus, similar to ScISC1, the C-terminal domain of ISCL is
essential for its catalytic activity. One possibility is that without the
transmembrane regions, ISCLD may not be able to efficiently
interact with membrane-bound substrates and phospholipids, as
proposed for ScISC1 [26,28].
When introduced into iscl
2, these modified ISCL proteins
(D116G, D200G, D383G, and ISCLD) did not reverse the defects
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2 promastigotes in culture, as the transfectants continued to
show more round cells and poor viability in stationary phase
(Fig. 3A–B). We also examined whether they were able to infect
murine macrophages. As shown in Fig. 3C–D, without a
functional ISCL, iscl
2 parasites could be internalized efficiently
by macrophages as they were easily detected at 2 hours post
infection but failed to survive after 24–28 hours. In contrast, WT
and iscl
2/+ ISCL parasites survived much better in macrophages
(Fig. 3C–D). Therefore, the IPCase/SMase activity of ISCL is
required for its function in Leishmania.
The IPCase activity is required for the maintenance of cell
shape and acid resistance in stationary phase
promastigotes
In culture, iscl
2 mutants replicated normally during log phase
but died rapidly in late stationary phase, especially when they were
grown in a pH 5.0 medium which mimicked the acidic condition
in mammalian phagolysosomes [22]. This hypersensitivity to acid
shock is responsible for the poor survival of iscl
2 in macrophages,
as the pretreatment of macrophages with chemicals that inhibit
phagolysosomal acidification significantly improved the viability of
iscl
2 in host cells [22]. Because ISCL is both a SMase and an
IPCase, we investigated which activity is required for acid
resistance in stationary phase promastigotes. When the C.
neoformans ISC1 (CnISC1) was introduced into iscl
2, no SMase
activity was detected (iscl
2/+CnISC1 in Fig. 4A and C), although
the IPCase activity was evident (iscl
2/+CnISC1 in Fig. 4B and D).
In contrast, when a HA-tagged Bacillus cereus SMase (HA-
BcSMase) was introduced into iscl
2, a strong SMase (iscl
2/+
HA-BcSMase in Fig. 4A and C) but no IPCase activity was
detected (iscl
2/+ HA-BcSMase in Fig. 4B and D). As controls, WT
and iscl
2/+HA-ISCL parasites exhibited both SMase and IPCase
activities (Fig. 4).
Notably, after being introduced into iscl
2, CnISC1 comple-
mented the acid resistance defect (Fig. 5) and restored cell
morphology in stationary phase promastigotes (Fig. S2). In
addition, iscl
2/+ CnISC1 parasites survived well in murine
macrophages (similar to WT parasites; Fig. 6A–B). Together,
these results suggest that the IPCase activity alone is sufficient to
confer resistance to acid shock and help promastigotes establish
infection in mammalian cells. The localization of CnISC1 in
Leishmania is not known and it would be interesting to determine
whether the mitochondrion-localization of IPCase is required for
its function.
Next, we examined whether the SMase activity alone can
complement the defects in iscl
2. In addition to HA-BcSMase, we
generated another SMase by fusing the first 18 amino acids of the
Figure 1. Temporal and spatial expression of ISCL in L. major. (A) Elevated ISCL transcript level in stationary phase promastigotes. L. major WT
promastigotes were cultured in M199 medium at a starting density of 1.0610
5 cells/ml and total RNA was extracted daily. The relative abundance of
ISCL mRNA was determined by quantative RT-PCR using the constitutively expressed rRNA45 gene as an internal control. EL: early log phase culture
(1–2610
6 cells/ml); LL: late log phase culture (6–10610
6 cells/ml); S1–S4: day 1–4 stationary phase culture (2.0–3.0610
7 cells/ml). *: p,0.05, **:
p,0.01. Error bars represent standard deviations from two independent experiments. (B) Increased expression of ISCL protein in stationary phase
promastigotes and lesion amastigotes. Left: whole cell lysates from WT late log phase promastigotes (LL), day 1–4 stationary phase promastigotes
(S1–S4), and late log phase promastigotes of iscl
2 and iscl
2/+ISCL were subjected to immunoblot analysis using the affinity purified anti-ISCL
antibody (top) or an anti-a-tubulin antibody as loading control (bottom). Right: immunoblot of cell lysates from WT day 3 stationary phase
promastigotes (S3 pro.) and lesion amastigotes (ama.). Each lane contained material from 1610
6 cells. (C–J) Localization of endogenous ISCL in L.
major. WT promastigotes (C–F) and amastigotes (G–J) were fixed and permeabilized with ethanol as described in Materials and Methods. Cells were
then labeled with rabbit anti-ISCL antibody, followed by staining with goat-anti-rabbit IgG-FITC (D, H) and Mitotracker Red 580 (E, I). (F) Overlay of D
and E.( J) Overlay of H and I. Control cells that were labeled with secondary antibody only did not show any green fluorescence (data not shown).
Experiments in C–F were performed three times and results from one representative set are shown here.
doi:10.1371/journal.pone.0031059.g001
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study. Asterisks represent the three aspartic acids (D116, D200, and D383) that were mutated; grey bars represent the region recognized by the anti-
ISCL peptide antibody; and black bars represent the transmembrane helices. (B) Western-blot to confirm the expression of mutated ISCL. Whole cell
lysates from WT, iscl
2, iscl
2/+ISCL, iscl
2/+ISCL D116G, iscl
2/+ISCL D200G, iscl
2/+ISCL D383G, iscl
2/+ISCLD and iscl
2/+pXG (empty vector)
promastigotes were probed with either anti-ISCL (top) or anti-a-tubulin (bottom) antibody. Each lane contained material from 6610
5 cells. (C–D) The
SMase and IPCase activities in log phase promastigotes were determined as described in Materials and Method. Error bars represent standard
deviations from 3 independent experiments.
doi:10.1371/journal.pone.0031059.g002
Figure 3. Mutated forms of ISCL failed to complement iscl
2 parasites. (A–B) Promastigotes were cultured in M199 medium and percentages
of round cells (defined as those promastigotes whose long axis is shorter than twice the length of the short axis) (A) and dead cells (B) were recorded
in late log (LL) and stationary phase promastigotes (S1–S5) as described [21]. Each group of bars represents cells in the following order (from left to
right): WT, iscl
2, iscl
2/+ISCL, iscl
2/+pXG, iscl
2/+ISCL D116G, iscl
2/+ISCL D200G, iscl
2/+ISCL D383G, and iscl
2/+ISCLD.( C–D) Stationary phase
promastigotes (N: WT, #: iscl
2, .: iscl
2/+ISCL, &: iscl
2/+ISCL D116G, %: iscl
2/+ISCL D200G, X: iscl
2/+ISCL D383G, e: iscl
2/+ISCLD) were used to
infect bone-marrow derived macrophages (Mws) from BALB/c mice at a ratio of 15 parasite per Mw. Percentages of infected Mws( C) and parasites per
100 Mws( D) were determined at 2, 24, 48, and 72 hours post infection as described. As a control, WT parasites were also used to infect Mws that were
activated with 100 ng/ml of LPS and 100 ng/ml of IFN-c (n:W T +activated Mws). Experiments were repeated 3 times and error bars represent
standard deviations.
doi:10.1371/journal.pone.0031059.g003
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surface including the flagellar surface) [31] to the N-terminus of
BcSMase. The resulting 59-HASPb-BcSMase-HA was similar to
HA-BcSMase in that it was highly active against SM but not IPC
when it was introduced into iscl
2 (iscl
2/+59-HASPb-BcSMase-HA
in Fig. 4). As shown in Fig. 7A–C, the 59-HASPb-BcSMase-HA
fusion protein was mainly localized at the flagellar membrane
although it was also visible at the cell membrane [11]. In contrast,
without the HASPb leader sequence, HA-BcSMase was primarily
found in the cytoplasm (Fig. 7D–F). These results allowed us to
evaluate whether the localization of SMase affects its function in
Leishmania. Importantly, despite their strong SMase activity,
neither HA-BcSMase nor 59-HASPb-BcSMase-HA restored acid
resistance or cell shape in iscl
2 during stationary phase (Figs. 5 and
S2), although they were able to somewhat improve iscl
2 survival in
macrophages (Fig. 6A–B). Together, these studies suggest that the
SMase activity alone cannot confer acid tolerance but can help
Leishmania establish infection in macrophages.
The SMase activity is required for amastigote
proliferation in mice
Although the CnISC1 (a sole IPCase) was sufficient to
complement the defects of iscl
2 promastigotes in culture, it could
not restore their virulence as the iscl
2/+ CnISC1 parasites failed to
induce pathology or proliferate in BALB/c mice (Fig. 6C–D) [21].
In contrast, the BcSMase (a sole SMase) was able to restore the
infectivity of iscl
2 in mice (Fig. 6C–D) but not cell morphology or
viability in culture (Figs. 5 and S2). The localization of SMase did
not appear to be crucial as both the cytoplasmic HA-BcSMase and
flagellum/plasma membrane-associated 59HASPb-BcSMase-HA
allowed iscl
2 parasites to regain virulence and proliferate normally
in mice (Figs. 6 and 7). Therefore, the SMase activity of ISCL is
required for the survival and proliferation of Leishmania in
mammals.
Discussion
Role of IPC degradation in Leishmania promastigotes
Promastigotes of Leishmania reside and multiply within the gut of
sandflies. Six-nine days after a blood meal, the replicative
procyclics differentiate into mammal-infective metacyclics in
response to nutrient depletion and/or low pH [24,32,33]. The
fact that IPCase contributes to cell shape and viability in culture
suggests that ISCL may be required for the optimal development
of promastigotes in sandfly. Based on its localization, ISCL may be
involved in the production of ceramide in the mitochondrial
membrane which could alter the permeability and/or other
functions of the mitochondria. It has been postulated that
promastigotes can utilize simple sugars and amino acids as energy
sources under anaerobic conditions [34,35]; however, when
nutrients are depleted (e.g. during the stationary phase in culture
and late stages in sandfly), parasites may be more dependent on
Figure 4. Introduction of a sole SMase or sole IPCase into iscl
2. Whole cell lysates from late log phase promastigotes of WT, iscl
2, iscl
2/+HA-
ISCL, iscl
2/+HA-BcSMase, iscl
2/+59HASPb-BcSMase-HA, and iscl
2/+CnISC1 parasites were incubated with NBD-labeled SM (A and C) or NBD-labeled
IPC (B and D) as described in Materials and Methods. Each reaction contained ,40 mg of total protein corresponding to 4610
6 cells. (A–B) After
incubation, lipids were extracted and separated by thin layer chromatography (TLC). Ceramide (Cer), a product of SMase and IPCase, migrates faster
than sphingomyelin (SM in A) or IPC (B). O: origin of migration. Positive control (+): 0.1 unit of purified BcSMase (A) or 0.1 unit of purified BcPI-PLC (B).
Negative control (2): boiled WT lysate. (C–D) Activity of SMase (C) or IPCase (D)i nLeishmania cell lysates was quantified after TLC analysis based on
the amount ceramide produced and the amount of protein in each reaction. Error bars represent standard deviations from 3 independent
experiments.
doi:10.1371/journal.pone.0031059.g004
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mitochondrial function may also explain the hypersensitivity of
iscl
2 to acidic pH, since the maintenance of cellular pH
homeostasis requires energy, e.g. from ATP hydrolysis [36,37].
Alternatively, the ISCL-induced ceramide production could confer
tolerance to acid shock. In mammalian cells, SMase-generated
ceramide plays important roles in stress response by activating
protein kinase C-zeta, protein phosphatase 2A and cathepsin D
[38], as well as by altering the structure/function of biological
membranes [39]. In Saccharomyces cerevisiae, ScISC1 regulates
cellular response to oxidative stress through the modulation of
the iron level [40,41] or a ceramide-dependent protein phospha-
tase [42]. In Cryptococcus neoformans, CnISC1 regulates the
production of phytoceramide when cells are exposed to low pH,
suggesting that IPC degradation may affect the plasma membrane
ATPase under acidic stress [18]. Our data indicate that SMase
alone (e.g. BcSMase) cannot restore cell shape and viability of iscl
2
promastigotes in culture (Figs. 5 and S2). This is likely due to the
lack of SM in promastigotes (while IPC is plentiful in
promastigotes). Further studies are needed to define the molecular
mechanism by which IPCase utilizes to confer acid resistance and
ensure cell survival under low nutrient conditions.
Although CnISC1 (a sole IPCase) successfully rescued iscl
2 in
murine macrophages, it failed to restore virulence in mice (Fig. 6)
[21]. These results suggest that by conferring acid tolerance, IPC
degradation contributes to Leishmania survival and differentiation
in the initial stage of infection (2–3 days), yet is insufficient for the
continuous proliferation of amastigotes in mammals. One
possibility is that SM is a more accessible substrate than IPC for
intracellular amastigotes (see discussion below). In mouse infection,
the BcSMase-complemented iscl
2 parasites did not show any
noticeable delay in lesion formation (Fig. 6C–D), which was likely
due to the relatively high dosage of infection (1610
6 parasites/
mouse footpad). These data indicate that although the in vitro
macrophage infection assay (usually lasting 2–5 days) is a fast and
convenient way to evaluate Leishmania virulence, it does have
limitations and cannot fully recapitulate parasite infection in
animals.
Role of SM degradation in Leishmania amastigotes
Our data suggest that the SMase activity of ISCL is necessary
and sufficient for amastigote proliferation in mice. It is possible
that SMase is needed to generate essential nutrients such as
ceramide and phosphocholine. While the latter can be used
towards the synthesis of phosphatidylcholine, it is not clear why
ceramide production is important for amastigotes. Future studies
will investigate whether the SMase-derived ceramide is needed for
the generation of IPC (present in amastigotes) or other crucial SL
metabolites. Alternatively, Leishmania amastigotes may utilize the
SMase activity of ISCL to remove excess SM in the phagolyso-
some which is rich in recycled lipids including SM. In mammals,
deficiency of lysosomal enzymes required for lipid metabolism can
lead to a series of metabolic disorders known as lysosomal storage
diseases (LSDs) [43]. Among these LSDs is the type A Niemann–
Pick disease (a severe neurodegenerative disorder) caused by SM
accumulation due to defects in the lysosomal acid SMase [44,45].
It is not entirely clear how SM accumulation causes such a serious
condition. One possibility is that the lack of SM turnover impairs
the dynamics of raft-associated membrane receptors, leading to
abnormality in signaling [46]. For Leishmania amastigotes, a lack of
ISCL may lead to SM accumulation on cell surface and disrupt the
membrane property, which could be detrimental to parasites.
Functional analysis of ISCL by mutagenesis revealed that three
conserved ASP residues, D116, D200, and D383, were essential for
both IPCase and SMase activity (Figs. 2–3). The C-terminal region
of ISCL including the two predicted transmembrane helices may be
required to maintain the overall conformation of the protein, as the
ISCLD mutant is non-functional (Figs. 2–3). Alternatively, these
membrane-bound motifs may be critical for the catalytic domain of
ISCLtogainaccesstolipid-basedsubstratessuchasIPCand SM,as
suggested for ScISC1 [25,27]. Notably, transfection experiments
showed that cytoplasmic- and flagellum/plasma membrane-local-
ized SMases (HA-BcSMase and 59HASPb-BcSMase-HA, respec-
tively) were able to complement iscl
2 growth and pathogenesis in
mice (Figs. 6 and 7), suggesting that the mitochondrial localization
of ISCL is not required for its function during the amastigote stage.
Taken together, we postulate that SL degradation possesses at least
two important roles during Leishmania life cycle. For promastigotes,
ISCL-mediated breakdown of IPC is important for parasite
development during the late stages in the sandfly when nutrients
become depleted and contributes to acid resistance. For amasti-
gotes, the degradation of host SM is required for long-term parasite
proliferation in mammals. Revealing the molecular mechanism by
which ISCL contributes to L. major infection will provide new
knowledge to Leishmania-host interaction. Future studies will also
determine whether the role of SL degradation is conserved in other
Leishmania species.
Materials and Methods
Ethics statement
This study was approved by the Animal Care and Use
Committee at Texas Tech University (PHS Approved Animal
Figure 5. The IPCase activity was required for acid resistance in
stationary phase promastigotes. Promastigotes were cultured
under either neutral pH (pH 7.4, A) or acidic pH (pH 5.0, B). Cell
viability in stationary phase (S1–S5) was determined by flow cytometry
after staining with propidium iodide. Each group of bars represents cells
in the following order (from left to right): WT, iscl
2, iscl
2/+HA-ISCL,
iscl
2/+HA-BcSMase, iscl
2/+59HASPb-BcSMase-HA, and iscl
2/+CnISC1.
Error bars represent standard deviations from 3 independent exper-
iments.
doi:10.1371/journal.pone.0031059.g005
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e31059Figure 7. Cellular localization of HA-tagged BcSMase. Late log phase promastigotes of iscl
2/+HA-BcSMase (A–C)o riscl
2/+59HASPb-BcSMase-
HA (D–F) were labeled with a monoclonal anti-HA antibody followed by anti-mouse IgG-FITC. (A, D) DIC images; (B, E) Hoechst staining of DNA; (C,
F) anti-HA staining. Control cells that were labeled with secondary antibody only did not show any green fluorescence (data not shown).
doi:10.1371/journal.pone.0031059.g007
Figure 6. The SMase activity alone was sufficient to restore virulence in iscl
2. (A–B) Bone marrow-derived Mws from BALB/c mice were
infected by stationary phase promastigotes (N: WT, #: iscl
2, .: iscl
2/+HA-ISCL, &: iscl
2/+CnISC1, %: iscl
2/+HA-BcSMase, X: iscl
2/+59HASPb-
BcSMase-HA, n:W T +activated Mws) at a ratio of 15 parasites per Mw. Percentages of infected Mws( A) and the number of parasites in 100 Mws( B)
were recorded. (C–D) BALB/c mice were infected in the footpads with day 3 stationary promastigotes (N: WT, #: iscl
2, .: iscl
2/+HA-ISCL, n: iscl
2/
+HA-BcSMase, &: iscl
2/+59HASPb-BcSMase-HA, %: iscl
2/+CnISC1) at 1610
6 parasites per mouse (5 mice per group). Lesion sizes were measured with
a caliper (C) and parasite numbers in infected footpads were determined by the limiting dilution assay (D). Error bars represent standard deviations
from 2 independent experiments.
doi:10.1371/journal.pone.0031059.g006
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for in the facility operated by the Animal Care and Resources
Center at Texas Tech University. The facility was inspected
monthly and animals were monitored daily by staff members. A
complete range of clinical veterinary services was available on a
24-hour basis and includes consultation, diagnostic work-up and
clinical care.
To minimize the pain and distress on animals without
compromising the quality of research, mice were under anesthesia
(through the peritoneal injection of ketamine hydrochloride/
xylazine) during recurring procedures including the injection of
Leishmania parasites into footpads, the recovery of parasites from
infected mice, and the measurement of lesion size using a caliper.
Usually, no more than one procedure was performed on one
mouse within a week. To prevent any potential secondary
infections and to reduce any potential pain/distress, mice were
monitored carefully (twice a week for appearance, size, movement,
and general health condition) and euthanized when the lesions
became too large (.2.5 mm for footpad infection).
Proper restraining and injection techniques were employed by
trained lab personnel to reduce pain and distress of animals. For
the isolation of macrophages and the determination of parasite
load in the infected footpads, mice were euthanized prior to the
operation.
Materials
BALB/c mice (female, 7–8 weeks old) were purchased from
Charles River Laboratories International. N-[6-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]hexanoyl]-sphingosine-1-phosphocho-
line (NBD-C6-sphingomyelin) and MitoTracker Red 580 were
purchased from Invitrogen Corp. N-[12-[(7-nitro-2-1,3-benzox-
adiazol-4-yl)amino]dodecanoyl]-sphingosine-1-phosphoinositol
(NBD-C12-IPC) was custom-synthesized by Avanti Polar lipids.
Bacillus cereus (ATCC strain 14579) was obtained from American
Type Culture Collection. The Rabbit anti-ISCL peptide antibody
was custom-produced by the Open Biosystems, Inc. The iScript
Select cDNA synthesis kit and the iTaq SYBR Green Supermix
with ROX were purchased from Bio-Rad Laboratories. All other
chemicals were purchased from VWR International or Fisher
Scientifics unless specified otherwise.
Molecular constructs for HA-BcSMase, 59HASPb-BcSMase-
HA, and mutated forms of ISCL
Procedure for the generation of molecular constructs was
described in the online supporting information (Supporting
Information S1). Oligonucleotides used in this study were
summarized in Table S1. All constructs were confirmed by
restriction enzyme digestion and DNA sequencing.
Leishmania culture and genetic manipulations
L. major LV39 clone 5 (Rho/SU/59/P) wild type (WT), iscl
2,
iscl
2/+ISCL, and iscl
2/+CnISC1 were grown in M199 medium
with 10% fetal bovine serum and other supplements as des-
cribed [21]. To generate iscl
2/+CnISC1, CnISC1 (accession
#DQ487762) was PCR amplified from C. neoformans genomic
DNA and cloned in the pIR1SAT vector as pIR1SAT-CnISC1
(B107), followed by transfection into iscl
2. To test if BcSMase
alone could complement iscl
2, pGEM-59UTR-phleo-DST IR-
HA-BcSMase-39UTR (B257), pGEM-59UTR-phleo-DST IR-
59HASPb-BcSMase-39UTR (B267), or pGEM-59UTR-phleo-DST
IR-HA-ISCL (B240) were introduced into iscl
2 by electroporation
[47] to generate iscl
2/+HA-BcSMase, iscl
2/+59HASPb-BcSMase-
HA, or iscl
2/+HA-ISCL, respectively.
To test if mutated forms of ISCL were functional, pXG-ISCL
D116G (B204), pXG-ISCL D200G (B208), or pXG-ISCL D383G
(B211) were introduced into iscl
2 and referred to as iscl
2/+ISCL
D116G, iscl
2/+ISCL D200G, iscl
2/+ISCL D383G, or iscl
2/+
ISCLD, respectively.
Analyses of cell growth, morphology and viability
Promastigotes were inoculated in either neutral (pH 7.4) or
acidic (pH 5.0) media (starting density=1.0610
5 cells/ml) as
previously described [22]; culture densities were monitored daily
using a hemacytometer; percentages of round cells were
determined by microscopy and cell viability was determined by
flow cytometry after staining with propidium iodide as previously
described [21]. In this study, round cells were referred to the
promastigotes whose long axis is shorter than twice the length of
their short axis.
Quantitative RT-PCR
Total RNA was extracted from WT promastigotes using the
Trizol reagent and the RNA quality was confirmed by
formaldehyde agarose gel electrophoresis [48]. First strand cDNA
was synthesized using the Bio-Rad iScript Select cDNA synthesis
kit. Quantitative RT-PCR was performed using an Applied
Biosystems 7500 Real-Time PCR system and the SYBR Green
qPCR kit. Briefly, PCR was set up in triplicates in low-profile 96
well microtitre plates. Each 25 ml reaction mixture contained 16
Taq SYBR Green supermix with ROX, 2 ml of first strand cDNA
and 100 nM of each 59 and 39 primer pair (P216/P217 for ISCL
and P167/P168 for rRNA45). The PCR amplification cycle
consisted of 2 min at 95uC for initial denaturation (1 cycle),
followed by 10 sec at 95uC and 45 sec at 60uC (40 cycles). The
relative expression level of ISCL was normalized to that of the
endogenous rRNA45 gene [49] using the comparative Ct method,
also known as 2
2DD(Ct) method [50,51]. Ct is the cycle threshold,
DCt is the difference in threshold cycles between ISCL and
rRNA45, and DDCt equals the amount of ISCL normalized to
rRNA45 and relative to the mid-log phase value.
Western-blot analysis
Promastigotes or purified amastigotes were collected and
resuspended in phosphate buffered saline (PBS) at 1610
8 cells/
ml. Cell extracts were prepared and western-blot was performed as
previously described [20]. ISCL was detected with the rabbit anti-
ISCL peptide antibody (1:500) and the goat anti-rabbit IgG
conjugated with HRP (1:2000). The detection of a-tubulin with a
rabbit anti-a-tubulin antibody (Sigma) (1:8000) was used as a
loading control. An enhanced chemiluminescence detection
system (Perkin Elmer) was used to detect signals.
SMase and IPCase assays
SMase and IPCase activities were assessed through in vitro
enzymatic assays as previously described [21]. Log phase
promastigotes were suspended in a lysis buffer containing
25 mM Tris pH 7.5, 0.1% Triton X100 and 16 protease
inhibitor at 2.0610
8 cells/ml and incubated for 5 min on ice.
Protein concentration was determined using a micro-BCA assay
(Pierce). For neutral SMase assay, 40 mgo fLeishmania protein
(,20 ml of lysate) was incubated in 100 ml of buffer containing
50 mM Tris pH 7.5, 5 mM MgCl2, 5 mM dithiothreitol, 0.1%
Triton X100, 11 nmol of PtS (Avanti), 2.8 nmol of unlabeled
sphingomyelin (Avanti), and 0.8 nmol of NBD C6-sphingomyelin.
After incubation at room temperature for 60 min, 1 ml of
chloroform, 0.5 ml of methanol, and 0.2 ml of water were added
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20 ml of chloroform: methanol (1:2). Thin layer chromatography
(TLC) was performed as we previously described [21] and plates
were scanned with a Storm 860 phosphoimager. Results were then
quantified to pmol/(mg6hour) after subtracting the value of
negative control (reaction using boiled WT lysate). 0.1 unit of
Bacillus cereus SMase (Sigma) was used as a positive control. For
IPCase assay, similar experiments were performed except: 1) lysate
was incubated in the absence of sphingomyelin and presence of
0.8 nmol of NBD C12-IPC; 2) TLC plates were developed in a
different solvent (chloroform:methanol:water=65:24:5); and 3) 0.1
unit of Bacillus cereus phosphatidylinositol phospholipase C (PI-
PLC, Sigma) was used as a positive control. Because L. major
promastigotes contain 1–2610
8 molecules of IPC per cell [52,53],
we took that amount into consideration while calculating the
activity of IPCase.
Macrophage infection
Bone marrow derived macrophages were obtained by inducing
the BALB/c femur bone marrow with 20 ng/ml of macrophage
colony-stimulating factor for 4 days, and infected withlatestationary
phase parasites (opsonizedwith 4% C57BL6mouse serum)ata ratio
of twenty parasites per one macrophage as previously described
[54]. Percentages of infected macrophages and the number of
parasites per 100 macrophages were determined microscopically
after staining with 1 mg/ml of Hoechst 33342 as previously
described [54]. As a control to show that Mw are immunologically
functional,WTparasiteswereusedtoinfectMwsthatwereactivated
with 100 ng/ml of LPS and 100 ng/ml of IFN-c.
Amastigote purification
Purification of lesion amastigotes was processed as described
[55] with minor modifications. Footpads of WT-infected BALB/c
mice were homogenized in DMEM on ice (25 ml of DMEM/
footpad). Homogenates were centrifuged (5 min at 33 g at 4uC) to
remove large cell debris. The supernatant was transferred into a
new tube and further centrifuged at 1847 g for 10 min (4uC) to
collect parasites. To lyse red blood cells, pellet was resuspended in
5 ml of 168 mM NH4Cl and incubated at room temperature for
10 min, and then diluted with 20 ml of DMEM. The recovered
amastigotes were filtered through a 40 mm cell strainer (Fisher).
After centrifugation (1847 g for 10 min at 4uC), cells were
resuspended in DMEM and counted using a hemacytometer
before further experiments.
Immunofluorescence microscopy
To determine the localization of endogenous ISCL, parasites
were fixed with 3.7% formaldehyde and permeablized with 100%
ethanol, followed by re-hydration with phosphate buffered saline
(PBS). Cells were first labeled with rabbit anti-ISCL antibody
(1:500 dilution in 0.5% BSA prepared in PBS) for 30 min. After
washing with PBS (3 times), parasites were incubated with goat
anti-rabbit IgG-FITC (1:1000 dilution in 0.5% BSA) for 30 min.
Cells were then washed again with PBS (3 times) and transferred to
poly-L-lysine coated coverslips by centrifugation (462 g for 5 min),
followed by staining with 350 nM of Mitotracker Red 580 for
30 min in darkness. Cells were then washed twice with PBS, once
with 50% ethanol, and stained with 2.5 mg/ml of Hoechst 33342
for 10 min. Images were acquired using an Olympus BX51
Upright Fluorescence Microscope equipped with a digital camera.
To determine the localization of 59HASPb-BcSMase-HA and
HA-BcSMase, promastigotes of iscl
2/+HA-BcSMase or iscl
2/
+59HASPb-BcSMase-HA were stained with a monoclonal anti-
HA antibody (Invitrogen; 1:500) followed by anti-mouse IgG-
FITC as described above.
Mouse footpad infection
Virulence of promastigotes was assessed using susceptible BALB/
c mice via footpad infection and limiting dilution assay (LDA) as
previously described [56,57]. Late stationary phase (,3 days after
reaching maximal culture density) promastigotes were centrifuged
at33 gfor5 mintoremoveaggregatesandresuspended inDMEM.
Parasites were injected into the footpads of 8-week old female
BALB/c mice (5 mice pergroup) at 1610
6 cells/mouse. Lesionsizes
were measured weekly using a Vernier caliper. Parasite loads in the
infected footpads were assessed by LDA.
Supporting Information
Supporting Information S1 Procedure for the generation
of molecular constructs used in this study.
(PDF)
Figure S1 The amino acid (AA) sequence of L. major
ISCL. Three aspartic acid residues (marked with asterisks) were
mutated to glycine in this study (as D116G, D200G, and D383G).
The boxed area (AA115–121) indicates the P-loop motif. AA241–
256 (dashed underline) represente the sequence recognized by the
anti-ISCL peptide antibody. The underlined C-terminal domain
(AA447–653) was removed to generate ISCLn. Two predicted
transmembrane helices are highlighted in grey (AA447–466 and
AA612–634).
(PDF)
Figure S2 SMase activity alone cannot restore the
morphological defect in iscl
2 promastigotes. Promasti-
gotes were inoculated in M199 medium and culture densities were
monitored daily (A). Percentages of round cells were determined
(B) as described in Materials and Methods. S1–S6: day 1
through 6 in stationary phase.
(PDF)
Table S1 Oligonucleotides used in this study.
(PDF)
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